Mikaela Dealissia

Davis Polk advised the underwriters in connection with a $38.4 million initial public offering of common stock of RAPT Therapeutics, Inc. RAPT Therapeutics’ common stock is listed on…

Davis Polk advised Youdao, Inc. on its SEC-registered initial public offering of 5,600,000 American Depositary Shares. Each ADS represents one Class A ordinary share of Youdao. Youdao has…

Davis Polk advised the underwriters in connection with the $648 million initial public offering by Datadog, Inc. of 24,000,000 shares of its Class A common stock. The Class A common stock…

Davis Polk is advising the Goldman Sachs Merchant Banking Division in connection with its investment in MedVet. Founded in 1869, The Goldman Sachs Group, Inc. is a leading global investment…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Zynga Inc. of $690 million aggregate principal amount of its 0.25% convertible senior notes due 2024,…

Davis Polk is advising Cornell Capital LLC on the merger of its portfolio company, Corelle Brands LLC, with Instant Brands, Inc. The transaction is expected to close by the end of the…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by 8x8, Inc. of $287.5 million aggregate principal amount of its 0.50% convertible…

Davis Polk advised the administrative agent, joint lead arrangers, joint bookrunners and senior managing agents, with respect to The Dun & Bradstreet Corporation’s $2.53 billion senior…

Davis Polk advised AC Immune SA in connection with its $117.5 million U.S. follow-on public offering. AC Immune sold 8,500,000 of its newly issued common shares and subscription rights…